[Is suxamethonium still useful for paediatric anaesthesia?]

Area of Science:

• Anesthesiology
• Pharmacology

Context:

• Suxamethonium is the sole depolarizing neuromuscular blocking agent in widespread anesthetic use.
• Its rapid onset and spontaneous reversal are advantageous, but potential complications like malignant hyperthermia and hyperkalemia require consideration.
• Pediatric patients exhibit increased sensitivity to suxamethonium's side effects due to developmental differences in neuromuscular junctions.

Purpose:

• To review the properties, benefits, and risks of suxamethonium in anesthesia.
• To highlight the specific risks associated with suxamethonium in pediatric patients, particularly malignant hyperthermia.
• To compare suxamethonium with newer agents like rocuronium and sugammadex for anesthetic muscle relaxation.

Summary:

• Suxamethonium offers rapid neuromuscular blockade and reversal, making it ideal for certain anesthetic procedures.
• However, it poses risks including malignant hyperthermia, hyperkalemia, and bradycardia, with heightened sensitivity in pediatric populations.
• While rocuronium and sugammadex provide alternatives, suxamethonium remains a primary choice for pediatric intubation due to its efficacy.

Impact:

• Understanding suxamethonium's unique profile is crucial for safe anesthetic practice, especially in pediatrics.
• Awareness of potential complications like malignant hyperthermia guides clinical vigilance and management strategies.
• The ongoing use of suxamethonium underscores the need for continued research into safer anesthetic agents and techniques for pediatric patients.